Ocular Therapeutix, Inc. is a biopharmaceutical company engaged in the development and commercialization therapies for eye conditions, including wet age-related macular degeneration (wet AMD), diabetic retinopathy and other ocular diseases. Co.'s commercial product, DEXTENZA, treats ocular inflammation and pain following eye surgery and ocular itching due to allergic conjunctivitis. Co. is also developing OTX-DED for short-term dry eye disease treatment and OTX-CSI for chronic dry eye disease management. It is conducting a Phase III trial for AXPAXLI to treat wet AMD and are also advancing PAXTRAVA in Phase III clinical development for primary open-angle glaucoma or ocular hypertension. We show 41 historical shares outstanding datapoints in our OCUL shares outstanding history coverage, used to compute OCUL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OCUL market cap history over the course of time is important for investors
interested in comparing OCUL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OCUL versus a peer is one thing; comparing
OCUL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OCUL can fluctuate over the course of history.
With this page we aim to empower investors researching OCUL by allowing them to research the OCUL market cap history. |
Free OCUL Email Alerts:
Video: The Importance of Market Cap
